• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于青光眼眼压调节和视神经损伤分数阶建模的量子启发式神经模糊滑模控制框架。

A quantum-inspired neural fuzzy sliding mode control framework for fractional-order modeling of intraocular pressure regulation and optic nerve damage in glaucoma.

作者信息

Amilo David

机构信息

Department of Mathematics, Near East University, Mersin 10, 99010, Nicosia, Cyprus.

Mathematics Research Center, Mersin 10, 99010, Nicosia, Cyprus.

出版信息

Sci Rep. 2025 Jul 2;15(1):23438. doi: 10.1038/s41598-025-99501-y.

DOI:10.1038/s41598-025-99501-y
PMID:40604309
Abstract

Glaucoma, a progressive neurodegenerative ocular disease, is primarily driven by elevated intraocular pressure (IOP), which results in optic nerve damage and irreversible vision loss. This study introduces a novel fractional-order mathematical model to capture the intricate dynamics of aqueous humor production, drainage, and the associated deterioration of the optic nerve in glaucoma. Building on this framework, this work proposes a Quantum-Inspired Neural Fuzzy Sliding Mode Control (QINF-SMC) framework, designed to address the nonlinear and time-varying nature of IOP regulation. The model highlights that persistent elevation in IOP leads to continuous optic nerve damage and disease progression, while impaired outflow resistance exacerbates glaucoma. Conversely, stable aqueous humor dynamics maintain normal IOP, preventing disease advancement. The proposed QINF-SMC framework integrates fractional-order calculus, fuzzy logic, and quantum-inspired optimization to achieve precise and adaptive control of IOP, mitigate optic nerve damage, and optimize aqueous humor dynamics. The framework achieves near-perfect 97.9% convergence, with excellent control stability and tightly regulated parameters, combining fast global optimization with precise refinement through advanced fractional-order dynamics. This approach offers a robust and innovative strategy for managing glaucoma, with potential implications for improving therapeutic outcomes and preserving vision.

摘要

青光眼是一种进行性神经退行性眼病,主要由眼内压(IOP)升高引起,IOP升高会导致视神经损伤和不可逆的视力丧失。本研究引入了一种新颖的分数阶数学模型,以捕捉青光眼患者房水生成、引流以及相关视神经退化的复杂动态过程。在此框架基础上,本研究提出了一种量子启发式神经模糊滑模控制(QINF-SMC)框架,旨在解决IOP调节的非线性和时变特性。该模型强调,IOP持续升高会导致视神经持续损伤和疾病进展,而流出阻力受损会加剧青光眼病情。相反,稳定的房水动态可维持正常的IOP,防止疾病进展。所提出的QINF-SMC框架整合了分数阶微积分、模糊逻辑和量子启发式优化,以实现对IOP的精确自适应控制,减轻视神经损伤,并优化房水动态。该框架实现了近97.9%的完美收敛,具有出色的控制稳定性和严格调控的参数,通过先进的分数阶动力学将快速全局优化与精确细化相结合。这种方法为青光眼管理提供了一种强大且创新的策略,对改善治疗效果和保护视力具有潜在意义。

相似文献

1
A quantum-inspired neural fuzzy sliding mode control framework for fractional-order modeling of intraocular pressure regulation and optic nerve damage in glaucoma.一种用于青光眼眼压调节和视神经损伤分数阶建模的量子启发式神经模糊滑模控制框架。
Sci Rep. 2025 Jul 2;15(1):23438. doi: 10.1038/s41598-025-99501-y.
2
Iridotomy to slow progression of visual field loss in angle-closure glaucoma.虹膜切开术减缓闭角型青光眼视野丧失的进展。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD012270. doi: 10.1002/14651858.CD012270.pub3.
3
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.用于预防激光小梁成形术后眼压暂时升高的围手术期药物。
Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2.
4
Cyclodestructive procedures for non-refractory glaucoma.非难治性青光眼的睫状体破坏手术
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD009313. doi: 10.1002/14651858.CD009313.pub2.
5
Multifaceted behavioral interventions to improve topical glaucoma therapy adherence in adults.多方面行为干预以提高成人局部青光眼治疗的依从性。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015788. doi: 10.1002/14651858.CD015788.pub2.
6
Effects and Safety of Press-Needle Therapy for Improving Visual Function and Eye Blood Circulation in Patients With Glaucoma With Controlled Intraocular Pressure: Study Protocol for a Multicenter Randomized Controlled Trial.眼压控制的青光眼患者中揿针疗法改善视功能和眼部血液循环的效果及安全性:一项多中心随机对照试验的研究方案
JMIR Res Protoc. 2025 Apr 1;14:e67737. doi: 10.2196/67737.
7
Peripheral iridotomy for pigmentary glaucoma.色素性青光眼的周边虹膜切开术
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD005655. doi: 10.1002/14651858.CD005655.pub2.
8
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.
9
Iridotomy to slow progression of visual field loss in angle-closure glaucoma.虹膜切开术延缓闭角型青光眼视野缺损的进展。
Cochrane Database Syst Rev. 2018 Jun 13;6(6):CD012270. doi: 10.1002/14651858.CD012270.pub2.
10
[Modeling and finite element analysis of human trabecular meshwork outflow pathways].[人小梁网流出途径的建模与有限元分析]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2025 Jun 25;42(3):585-591. doi: 10.7507/1001-5515.202407037.

本文引用的文献

1
Mathematical Modeling and Artificial Intelligence to Explore Connections Between Glaucoma and the Gut Microbiome.利用数学建模和人工智能探索青光眼与肠道微生物群之间的联系。
Medicina (Kaunas). 2025 Feb 14;61(2):343. doi: 10.3390/medicina61020343.
2
Impact of aging on anterior segment morphology and aqueous humor dynamics in human Eyes: Advanced imaging and computational techniques.衰老对人眼眼前节形态和房水动力学的影响:先进成像与计算技术
Biocybern Biomed Eng. 2025 Jan-Mar;45(1):62-73. doi: 10.1016/j.bbe.2025.01.004. Epub 2025 Jan 24.
3
The molecular mechanisms underlying retinal ganglion cell apoptosis and optic nerve regeneration in glaucoma (Review).
青光眼视网膜神经节细胞凋亡及视神经再生的分子机制(综述)
Int J Mol Med. 2025 Apr;55(4). doi: 10.3892/ijmm.2025.5504. Epub 2025 Feb 14.
4
Circadian Disruption in Glaucoma: Causes, Consequences, and Countermeasures.青光眼的昼夜节律紊乱:原因、后果及应对措施
Front Biosci (Landmark Ed). 2024 Dec 3;29(12):410. doi: 10.31083/j.fbl2912410.
5
Advancements in Ocular Modelling and Simulations: Key Considerations and Case Studies.眼部建模与模拟的进展:关键考量因素及案例研究
AAPS PharmSciTech. 2024 Dec 17;26(1):14. doi: 10.1208/s12249-024-03001-7.
6
Emerging strategies targeting genes and cells in glaucoma.青光眼治疗中针对基因和细胞的新兴策略。
Vision Res. 2025 Feb;227:108533. doi: 10.1016/j.visres.2024.108533. Epub 2024 Dec 6.
7
A silent interplay between elevated intraocular pressure, glaucoma, and hypertension.眼内压升高、青光眼和高血压之间的无声相互作用。
Hypertens Res. 2025 Mar;48(3):1208-1210. doi: 10.1038/s41440-024-02038-2. Epub 2024 Dec 5.
8
An Emerging Multi-mechanism and Multi-modal Approach in Interventional Glaucoma Therapy.一种新兴的介入性青光眼治疗中的多机制和多模式方法。
Ophthalmol Ther. 2025 Jan;14(1):13-22. doi: 10.1007/s40123-024-01073-z. Epub 2024 Nov 30.
9
Global incidence and risk factors for glaucoma: A systematic review and meta-analysis of prospective studies.全球青光眼发病率及危险因素:一项前瞻性研究的系统评价和荟萃分析。
J Glob Health. 2024 Nov 8;14:04252. doi: 10.7189/jogh.14.04252.
10
Advances in understanding glaucoma pathogenesis: A multifaceted molecular approach for clinician scientists.青光眼发病机制研究进展:临床科学家的多方面分子研究方法
Mol Aspects Med. 2023 Oct 27;94:101223. doi: 10.1016/j.mam.2023.101223.